Search clinical trials for: AZD2811
Total 260 results
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaCompletedAdvanced Solid TumoursUnited States
-
Samsung Medical CenterWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
AstraZenecaCompletedStudy to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male SubjectsRefluxNetherlands, Belgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Adenocarcinoma AJCC v7 | Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Prostate Adenocarcinoma With Neuroendocrine...United States
-
AstraZenecaTerminated
-
AstraZenecaParexelCompleted
-
AstraZenecaCompleted
-
Massachusetts General HospitalUnited States Department of Defense; AstraZenecaCompletedMeningioma | Neurofibromatosis 2United States
-
AstraZenecaTerminatedHeart FailureDenmark, Finland, Netherlands, United States, Sweden
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Mayo ClinicNational Center for Advancing Translational Sciences (NCATS)Completed
-
AstraZenecaNot yet recruitingHepatocellular Carcinoma | Prostate CancerUnited States
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, France, Netherlands, Belgium, Taiwan, Slovakia, Japan, Czechia, Hungary, Australia, Bulgaria, Poland, Russian Federation, Brazil, Denmark, Turkey, Sweden, Canada
-
Massachusetts General HospitalNational Cancer Institute (NCI); AstraZenecaActive, not recruiting
-
AstraZenecaParexelCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaQuintiles, Inc.CompletedPart A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years. | Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, Denmark, Finland, Netherlands, Norway
-
The Christie NHS Foundation TrustClinical Trials Unit, ManchesterCompleted
-
University Health Network, TorontoAstraZenecaCompletedOvarian CancerCanada
-
AstraZenecaParexelCompleted
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, Germany, South Africa, Spain, United Kingdom, Italy, Argentina, Bulgaria, Mexico, Turkey, Poland, Netherlands
-
Se-Hoon LeeTerminatedAZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (SUKSES-N5)SCLC, RecurrentKorea, Republic of
-
University Health Network, TorontoAstraZenecaActive, not recruitingPancreatic Adenocarcinoma | Leiomyosarcoma | Mismatch Repair Proficient Colorectal CancerCanada
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
AstraZenecaParexelCompletedCardiovascular DiseaseUnited States
-
AstraZenecaTerminated
-
AstraZenecaCompleted
-
CCTU- Cancer ThemeAstraZeneca; Cancer Research UK; University of CambridgeRecruiting
-
AstraZenecaQuotient SciencesCompletedCardiovascular DiseaseUnited Kingdom
-
Samsung Medical CenterWithdrawnSolid TumorKorea, Republic of
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompletedAdvanced CancerUnited Kingdom
-
AstraZenecaParexelCompletedSafety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaParexel; Covance; The Doctors Laboratory; Industrias Farmacéuticas Almirall S.A.CompletedChronic Obstructive Pulmonary Disease - COPDUnited Kingdom
-
AstraZenecaCompleted
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States, Australia, Bulgaria, Czechia, Hungary, Poland, Romania, Serbia, Slovakia, Spain
-
AstraZenecaActive, not recruiting
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States, Australia, Hungary, Bulgaria, Czechia, Poland, Romania, Serbia, Spain
-
National Cancer Institute (NCI)AstraZenecaActive, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Advanced Malignant Solid Neoplasm | Unresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | Stage IIIA Lung Non-Small... and other conditionsUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | Lung Disease Causing Persistent Narrowing of the AirwaysUnited Kingdom
-
AstraZenecaTerminatedHealthyUnited Kingdom
-
The Christie NHS Foundation TrustAstraZeneca; Cancer Research UKTerminatedRectal CancerUnited Kingdom
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom